Notably, the data on the contribution of other adipokines [resistin, retinol binding protein-4 (RBP4), visfatin, chemerin, and irisin] to the occurrence and progression of NAFLD are relatively limited and inconclusive, which needed to be further explored. The gene discussed is RARRES2; the disease is metabolic dysfunction-associated steatotic liver disease.